NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









DigiFluidic Bio-Technology

DigiFluidic Bio-Technology

Private
SingaporeHealthcare & Life Scienceshttps://digifluidic.com/

Last Round

Series A

Extension

Sep 29, 2022

Total Funding Raised

$15.45M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

DigiFluidic Bio-Technology is a biotechnology company that develops a fully automated, programmable digital fluidic platform for a wide range of life science applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

digital microfluidicsnucleic acid analysispoint-of-care testingPOCTlab-on-a-chiprapid diagnosticsmolecular diagnosticsmicrofluidic chipsportable diagnosticsin vitro diagnosticsbiotech equipmentfood safety testinganimal disease detectionrazor and blade modelODM/OEM services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DigiFluidic Bio-Technology Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DigiFluidic Bio-Technology Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionSep 29, 2022

DigiFluidic Bio-Technology Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 40% MoM.

  • Apr 1, 2026

    Monthly visitors increased 56% MoM, reaching 1.4K.

DigiFluidic Bio-Technology Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DigiFluidic Bio-Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DigiFluidic Bio-Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSingapore
Employee Range2
Year Founded2021
Last FundingSep 29, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.